Launch week offerEnds in00h00m00s

annual Promonthly Pro

Markus Mezger

University of Tübingen

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (24)

Collaborators (5)

Manon Queudeville

Ana S. Guerreiro Stucklin

University of Zurich

Jan Frederic Weller

University Medical Center Hamburg-Eppendorf

Christian Sutter

Staff Scientist/PhD

University Hospital Heidelberg

Sasan Darius Adib

University of Tuebingen

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Markus Mezger

Research Interests

Make your next move.

Explore related searches

Articles (24)

Collaborators (5)

Manon Queudeville

Ana S. Guerreiro Stucklin

Jan Frederic Weller

Christian Sutter

Sasan Darius Adib

Make your next move.

Markus Mezger

Research Interests

Make your next move.

Explore related searches

Articles (24)

Occurrence of Extramedullary Relapses in Pediatric Acute Lymphoblastic Leukemia After Treatment With Blinatumomab

Real-world outcomes of the mesenchymal stromal cell product tomostrocel in heavily pretreated pediatric patients with refractory acute graft-&lt;i&gt;versus&lt;/i&gt;-host disease

Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model

Selpercatinib as First-Line Therapy in a 9-Month-Old Infant With Metastatic <i>RET</i> Fusion–Positive Sarcoma: A Case Report

Protracted Febrile Illness and Coma in an Adolescent with Sickle Cell Disease and Malaria

Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10

Prophylactic and pre-emptive donor lymphocyte infusion in patients with acute myeloid leukemia and myelodysplastic syndrome: validation of current recommendations and proposal of a modified outcome assessment.

MRI-based, three-dimensionally assessed tumor burden and growth velocity to predict visual acuity deterioration in optic pathway glioma — results of a retrospective longitudinal analysis

Revolutionizing pediatric gene and cell therapy: The hope for lipid-based nanoparticles in blood disorders

Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing

Accelerated generation of gene‐engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9

Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas.

Transferring measurable residual disease measurement in pediatric acute lymphoblastic leukemia from quantitative real-time PCR to digital droplet PCR.

Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies.

CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells

A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy <i>in vivo</i>.

Generation of a heterozygous and a homozygous CSF1R knockout line from iPSC using CRISPR/Cas9.

Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing

Preclinical Evaluation of CRISPR-Edited CAR-NK−92 Cells for Off-The-Shelf Treatment of AML and B-ALL

CRISPR medicine for blood disorders: Progress and challenges in delivery.

Time-dependent analysis of adoptive immunotherapy following sequential FLAMSA-reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk myeloid neoplasia.

A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy.

Somatic Reversion of a Novel <i>IL2RG</i> Mutation Resulting in Atypical X-Linked Combined Immunodeficiency

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.

Collaborators (5)

Manon Queudeville

Ana S. Guerreiro Stucklin

Jan Frederic Weller

Christian Sutter

Sasan Darius Adib

Make your next move.

Real-world outcomes of the mesenchymal stromal cell product tomostrocel in heavily pretreated pediatric patients with refractory acute graft-<i>versus</i>-host disease